Literature DB >> 14654522

The Role of p63 and p73 in tumor formation and progression: coming of age toward clinical usefulness. Commentary re: F. Koga et al., Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin. Cancer Res., 9: 5501-5507, 2003, and P. Puig et al., p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder Cancer. Clin. Cancer Res., 9: 5642-5651, 2003.

Ute M Moll1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14654522

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  11 in total

1.  Aberrant expression of β-catenin and its association with ΔNp63, Notch-1, and clinicopathological factors in oral squamous cell carcinoma.

Authors:  Gokulan Ravindran; Halagowder Devaraj
Journal:  Clin Oral Investig       Date:  2011-09-01       Impact factor: 3.573

2.  Ki-67 and Cell Cycle Regulators p53, p63 and cyclinD1 as Prognostic Markers for Recurrence/ Progression of Bladder Urothelial Carcinoma.

Authors:  Saba El-Gendi; Ghada Abu-Sheasha
Journal:  Pathol Oncol Res       Date:  2017-05-09       Impact factor: 3.201

3.  Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 cases.

Authors:  Eva Compérat; Philippe Camparo; Rachel Haus; Emmanuel Chartier-Kastler; Stephane Bart; Annick Delcourt; Alain Houlgatte; Richard François; Fréderique Capron; Annick Vieillefond
Journal:  Virchows Arch       Date:  2005-11-08       Impact factor: 4.064

4.  Expression and prognostic significance of TAp73 and ΔNp73 in FIGO stage I-II cervical squamous cell carcinoma.

Authors:  Weipei Zhu; Xiaohong Pan; Zhujuan Yang; Pengfei Xing; Yongshen Zhang; Feng Li; Xueguan Lu
Journal:  Oncol Lett       Date:  2015-03-17       Impact factor: 2.967

5.  Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence.

Authors:  Danae Papadogianni; Nikolaos Soulitzis; Demetrios Delakas; Demetrios A Spandidos
Journal:  Tumour Biol       Date:  2013-11-11

6.  Sequence variant on 3q28 and urinary bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study.

Authors:  Mariana C Stern; David Van Den Berg; Jian-Min Yuan; David V Conti; Manuela Gago-Dominguez; Malcolm C Pike; Yong-Bing Xiang; Yu-Tang Gao; Victoria K Cortessis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-20       Impact factor: 4.254

7.  p63 expression defines a lethal subset of muscle-invasive bladder cancers.

Authors:  Woonyoung Choi; Jay B Shah; Mai Tran; Robert Svatek; Lauren Marquis; I-Ling Lee; Dasom Yu; Liana Adam; Sijin Wen; Yu Shen; Colin Dinney; David J McConkey; Arlene Siefker-Radtke
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

8.  Diagnostic value of P63 in differentiating normal gestation from molar pregnancy.

Authors:  Mitra Heidarpour; Marzieh Khanahmadi
Journal:  J Res Med Sci       Date:  2013-06       Impact factor: 1.852

9.  PLK2 phosphorylates and inhibits enriched TAp73 in human osteosarcoma cells.

Authors:  Zheng Bo Hu; Xiao Hong Liao; Zun Ying Xu; Xiao Yang; Chao Dong; An Min Jin; Hai Lu
Journal:  Cancer Med       Date:  2015-12-02       Impact factor: 4.452

10.  Polo-like kinase 2 acting as a promoter in human tumor cells with an abundance of TAp73.

Authors:  ZhengBo Hu; ZunYing Xu; XiaoHong Liao; Xiao Yang; Cao Dong; KuaDi Luk; AnMin Jin; Hai Lu
Journal:  Onco Targets Ther       Date:  2015-11-20       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.